Candioli Pharma

What Candioli Pharma does

Candioli Pharma is an Italian pharmaceutical company founded in 1882 in Rome by Dr. Attilio Candioli and now headquartered in Beinasco (Turin), Italy. The company manufactures and sells a diversified portfolio of veterinary medicines and supplements, medical-surgical devices (insecticides and repellents), animal hygiene products, and human antiparasitic products, structured across four operating lines: Veterinary Line (Italian market), Human Line centered on the historic MOM brand, Candioli in the World (international distribution), and Vetark (exotic animals, acquired 2018). Core product families include the Florentero intestinal health line (FAST, ACT, Complex), BURAN respiratory formula, MOM antiparasitic products, and specific veterinary medicines (Milprazon, Marfloxin, Selames, Gastazole, Cystocure, OSTEOPEN, OTOXOLAN). The proprietary technology is built around a 4,226 m2 GMP-compliant production facility operated by wholly-owned subsidiary ACEL pharma Srl, with approximately 2,000 m2 of recently refurbished manufacturing space, ISO 9001:2023 quality certification, and Italian Ministry of Health authorization for veterinary medicines and medical-surgical devices.

The company's business model is built on a direct field sales force (scientific information representatives) visiting over 7,000 veterinary clinics daily across Italy, organized into two specialized teams with distinct therapeutic competencies. Domestic distribution is supplemented through pet shops, veterinary pharmacies, and human pharmacies for MOM products. International markets are served through export managers, distributors, and commercial partners in over 50 countries, with wholly-owned subsidiaries including ACEL pharma (production) and Vetark Products Ltd (UK). The company additionally offers third-party contract manufacturing services covering formulation development, production, packaging, and regulatory support. Customer engagement is reinforced through the Vetcampus digital training portal (launched July 2020), which provides training paths, webinars, case studies, and a VetCommunity. Revenue is generated primarily through one-time product sales across veterinary and human pharmaceutical categories, with no public pricing disclosure or subscription model evident.

The company is privately held under four generations of family ownership, with no external institutional investors or parent company identified. Leadership is composed of Luca Cravero Candioli (General Manager) and Dr. Enrica Candioli (President). The company has earned three consecutive Deloitte Best Managed Companies Awards (2020, 2021, 2023), Gender Equality Certification (2025), and registration in Italy's National Register of Historic Enterprises (2026).

Name

Candioli Pharma

Legal name

Candioli srl

Website

https://candioli.it

Company type

Private

Founded year

1882

Operating status

Operating

Headcount range

11–50 employees

Short description

Candioli Pharma is an Italian family-owned pharmaceutical company founded in 1882 that manufactures and sells veterinary medicines, supplements, hygiene products, and antiparasitic treatments for animals, plus the historic MOM human antiparasitic brand, distributed through a direct field sales force covering 7,000+ Italian veterinary clinics and partners in 50+ countries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm) (HLAMAEAD)

akta.pro secondary industries

Immune Support Supplements (HLAMALAE), Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

Keywords

• Veterinary pharmaceuticals
• Antiparasitic medicines
• Animal hygiene products
• Veterinary supplements
• Pet healthcare products

Headquarters

HQ city

Beinasco

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Veterinary pharmaceutical products: Manufacture and sale of antiparasitic veterinary medicines for pets, birds, and athlete horses, including products for dogs, cats, horses, and exotic animals through brands including Florentero, Milprazon, Marfloxin, Selames, Gastazole, Cystocure, Evexia plus, OSTEOPEN, and OTOXOLAN.
2. Human antiparasitic products (MOM line): Production and commercialization of antiparasitic products for human use, including the historic MOM brand (shampoo, lotions, emulsions) for pediculosis treatment and prevention.
3. Medical-surgical devices: Production and sale of insecticides for domestic and civil use and insect repellents for humans and animals in various forms (liquids, solutions, suspensions, sprays, shampoos, foams, powders, semisolids).
4. Animal hygiene products: Production of dermo-protective lotions, lenitive shampoos, oral hygiene pastes, mouth rinses, ear hygiene products, and ointments for dogs, cats, birds, and horses.
5. Third-party manufacturing (contract manufacturing): Candioli guarantees a complete service for the design, production and marketing of products for animals and humans on behalf of third parties, from raw material research to product analysis, formulation development, production, packaging, and technical-regulatory assistance.
6. International export: Export of veterinary and human pharmaceutical products to over 50 countries through distributors and commercial agreements, including the UK subsidiary Vetark Products Ltd for exotic animal products.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Candioli Pharma manufactures and sells antiparasitic medicines for human use and a broad portfolio of veterinary products (medicines with antiparasitic action, medical-surgical devices such as insecticides and repellents, and animal hygiene products) covering pets, birds, athlete horses, and exotic animals. The company also provides contract manufacturing services for third parties, encompassing raw material research, formulation, production, packaging, and technical-regulatory assistance under GMP and ISO 9001 standards.

Product overview

Candioli Pharma operates as a diversified pharmaceutical company with four main product lines: Veterinary Line (antiparasitic products, dermo-protective and hygiene products for pets, birds, and horses in Italy), Human Line featuring the historic MOM brand (anti-lice treatments for over 100 years), international distribution through Candioli in the World (present in 50+ countries), and Vetark (acquired UK brand for exotic animal products). The portfolio includes specific veterinary medicines like Milprazon (dewormer), Marfloxin (antibiotic), and Selames (spot-on parasite treatment), gastrointestinal supplements (Florentero Complex/FAST, Gastazole), respiratory products (BURAN), and bone health products (OSTEOPEN). The company also operates Vetcampus, a digital training platform for veterinarians.

Differentiator

Problem solved

Functional benefit

Brands

• MOM: Anti-lice range for human use; recognized as a historic brand (Marchio storico) for over 100 years
• MOM Care
• MOM Zero
• Florentero
• BURAN
• Evexia plus
• Cystocure
• Gastrocure
• Vetark
• Vetcampus
• Matosto
• Marfloxin
• Milprazon
• Selames
• Otoxolan
• Osteopen

Products and services

• Florentero Complex Veterinary intestinal health product for dogs and cats that stabilizes physiological digestion in cases of acute and chronic diarrhea, containing over 11 billion probiotics with three bacterial strains, available in tablet and paste formats.
• Florentero FAST Veterinary product for acute intestinal absorption disorders in dogs and cats, combining clinoptilolite, tannic acid, probiotic Lactobacillus acidophilus CECT 4529, FOS prebiotics, and the HECO electrolyte complex to restore hydrosaline balance.
• BURAN Veterinary respiratory function supplement for animals combining an exclusive blend of plant extracts (Arthrospira platensis, fermented pineapple, ivy, Glycyrrhiza glabra, Allium sativum, Thymus vulgaris, Hedera helix) with Vitamins C and E.
• Milprazon Veterinary deworming medicine combining Milbemycin oxime and Praziquantel, available in multiple dosage strengths (2.5mg/25mg, 4mg/10mg, 12.5mg/125mg, and 16mg/40mg tablets) for dogs and cats.
• Marfloxin Veterinary antibiotic containing Marbofloxacin, available in 5mg, 20mg, and 80mg formulations for the treatment of bacterial infections in animals.
• Selames Topical spot-on solution containing Selamectin for external parasite treatment in cats and dogs, available in multiple strengths from 15mg to 240mg.
• OSTEOPEN Veterinary product formulated to support bone health in animals.
• Gastazole Gastrointestinal product for veterinary use addressing digestive disorders in animals.
• OTOXOLAN Veterinary product formulated for ear care applications in animals.
• Evexia plus Veterinary product in Candioli's portfolio, presented at Zoomark 2023 as part of the company's expanding therapeutic range.
• Cystocure (including Cystocure pasta) Veterinary urinary health product line including a pasta format addition for the management of lower urinary tract conditions in companion animals.
• MOM antiparasitic range (MOM, MOM Care, MOM Zero) Historic Italian brand of human antiparasitic products for prevention and treatment of pediculosis (head lice), available as shampoos, lotions, and emulsions across the MOM, MOM Care, and MOM Zero sub-lines. Recognized as a historic Italian trademark with over 100 years of continuous market presence.
• Vetark product range for exotic animals Range of products specifically formulated for exotic animals, marketed through the wholly-owned UK subsidiary Vetark Products Ltd acquired in 2018 as Candioli's first foreign subsidiary.
• Animal hygiene product range Range of animal hygiene products including dermo-protective lotions, lenitive shampoos, oral hygiene pastes, mouth rinses, ear hygiene products, and ointments for dogs, cats, birds, and horses, manufactured under UNI EN ISO 9001 quality standards.
• Medical-surgical devices (insecticides and repellents) Insecticides for domestic and civil use and insect repellents for humans and animals, produced under authorization from the Italian Ministry of Health in various formats (liquids, solutions, suspensions, sprays, shampoos, foams, powders, semisolids).
• Contract manufacturing services for third parties End-to-end contract manufacturing service covering raw material research, formulation development, production, packaging, product analysis, and technical-regulatory assistance for animal and human products on behalf of third-party clients, conducted under GMP rules at the ACEL pharma facility.

Quantifiable outcome

• Over 7,000 veterinary clinics visited daily across Italy
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered major, minor and core.

• BioctalmajorChannel Partner/ Reseller/ Distributor · 1 January 2025Local distributor in Brazil for WSAVA 2025 in Rio de Janeiro. Demonstrated professional passion and commitment in representing Candioli Pharma at the international veterinary congress.
• CONAI (Consorzio Nazionale Imballaggi)minorGTM or Marketing Partner · 1 January 2021Partnership with 21 associations and supply chain consortia for environmental labeling events. CONAI selected the Florentero ACT packaging as a Good Ideas product in the pharmaceutical sector for its innovative environmental labeling developed internally by Candioli.
• Vetark Products LtdcoreStrategic or Co-development Partner · 1 January 2018Acquired in 2018 as Candioli Pharma's first foreign subsidiary, based in the UK. Specializes in products for exotic animals, expanding the company's international presence and product portfolio in the exotic pet segment.
• ExtonVetcoreStrategic or Co-development Partner · 1 January 2004Acquired in 2004 as part of the company's international expansion strategy, contributing to the global growth of Candioli Pharma's veterinary product distribution.
• ACEL pharma SrlcoreStrategic or Co-development PartnerProduction company of the Candioli group, authorized by the Italian Ministry of Health for production of veterinary medicines with antiparasitic action, medical-surgical devices (insecticides/repellents), and animal hygiene products. Operates the main production facility at Via Manzoni, 2, Beinasco (TO).
• International commercial partners (Europe, North America, South America, Asia)majorChannel Partner/ Reseller/ DistributorCandioli Pharma has commercial agreements with partners in European, North American, South American, and Asian countries. Products are distributed in over 50 countries through these partnerships.
• Deloitte PrivateminorOthersCandioli participated in Deloitte's Best Managed Companies multi-year growth program, receiving the BMC Award for three consecutive years (2020, 2021, 2023). The program provides expert guidance on business development and strengthening.
• ALTIS Graduate School of Sustainable Management, Università Cattolica del Sacro CuoreminorOthersAcademic partner in the Deloitte Best Managed Companies Award program. Contributes to the evaluation criteria for the award alongside ELITE-Gruppo Euronext and Piccola Industria di Confindustria.
• ELITE-Gruppo EuronextminorOthersPartner in the Deloitte Best Managed Companies Award program supporting Italian business excellence alongside Confindustria and Altis.
• Confindustria (Piccola Industria)minorOthersConfindustria's Piccola Industria is a partner in the Deloitte Best Managed Companies Award program recognizing excellence in Italian entrepreneurship.

Scale indicators8 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Vetoquinol: Independent French veterinary pharmaceutical company focused on companion animals and livestock, with overlapping therapeutic areas (parasiticides, antibiotics, dermatology) and a European-centric manufacturing footprint similar to Candioli's.
• Virbac: France-based global animal-health pharmaceutical company with a comparable portfolio across parasiticides, dermatology, antibiotics and specialty nutrition for companion animals, fish and livestock. Closely comparable in product mix (especially parasiticides and dermatology) and in veterinary-clinic channel focus.
• Ceva Santé Animale: Global veterinary pharmaceutical group with strong European presence and a comparable focus on companion-animal parasiticides, vaccines and specialty products. Comparable as a privately held multi-category animal-health player pursuing international expansion.
• Dechra Pharmaceuticals: UK-listed veterinary pharmaceuticals specialist concentrated in companion-animal therapeutics, dermatology, endocrine and parasiticides. Highly comparable specialty-portfolio overlap and European veterinary distribution model before its 2024 take-private.
• Fatro: Italian veterinary pharmaceutical manufacturer producing parasiticides, antibiotics and specialty products for companion and farm animals. Most direct domestic competitor and counterpart in scale, channel (Italian vet clinics) and product mix.
• Calier (Invesa group): Spanish veterinary pharmaceutical manufacturer within the Invesa group, producing parasiticides, anti-infectives and specialties for companion animals. Comparable regional European competitor with similar GMP manufacturing and export focus.

Emerging players

• ACM Pharma (animal health CDMO): European CDMO offering third-party veterinary pharmaceutical manufacturing services. Comparable to Candioli's contract manufacturing offering as a more focused, smaller-scale specialist alternative for animal-health brands seeking outsourced production.

Broad incumbents

• MSD Animal Health (Merck Animal Health): Global animal-health division of Merck offering parasiticides (Bravecto, etc.), vaccines and pharmaceuticals. Direct competitor in parasiticide categories but with substantially larger R&D and distribution capabilities.
• Zoetis: Largest global animal-health company offering parasiticides, vaccines, dermatology, diagnostics and nutrition. Overlaps with Candioli across multiple categories (notably parasiticides and dermatology) but operates at vastly broader scale and global reach.
• Boehringer Ingelheim Animal Health: Major incumbent in veterinary pharmaceuticals and vaccines across companion and production animals. Competes broadly with Candioli in parasiticides and respiratory therapeutics, though at much larger scale and with a global direct-market model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/candioli-farmaceutici

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Candioli Pharma